SNDL Inc. 6-K Filing

From the Filing

0001193125-25-262922.txt : 20251104 0001193125-25-262922.hdr.sgml : 20251104 20251103181026 ACCESSION NUMBER: 0001193125-25-262922 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20251103 FILED AS OF DATE: 20251104 DATE AS OF CHANGE: 20251103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SNDL Inc. CENTRAL INDEX KEY: 0001766600 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39005 FILM NUMBER: 251445608 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 919 11 AVENUE SW STREET 2: SUITE 300 CITY: CALGARY PROVINCE COUNTRY: Z4 BUSINESS PHONE: 14039485227 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 919 11 AVENUE SW STREET 2: SUITE 300 CITY: CALGARY PROVINCE COUNTRY: Z4 FORMER COMPANY: FORMER CONFORMED NAME: Sundial Growers Inc. DATE OF NAME CHANGE: 20190131 6-K 1 sndl-6-k-2025_q3.htm 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2025 Commission File Number 001-39005 SNDL INC. (Registrant’s name) #101, 17220 Stony Plain Road NW Edmonton, AB T5S 1K6 Tel.: (780) 944-9994 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☐ Form 40-F ☒       INCORPORATION BY REFERENCE This report on Form 6-K shall be deemed to be incorporated by reference in SNDL Inc.’s registration statements on Form S-8 (File No. 333-233156, File No. 333-262233, File No. 333-267510, File No. 333-269242, File No. 333-278683 and File No. 333-286169) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     SNDL INC. Date: November 3, 2025 By: /s/ Alberto Paredero Quiros   Name: Alberto Paredero Quiros   Title: Chief Financial Officer   EXHIBIT   Exhibit   Description of Exhibit 99.1   Condensed Consolidated Interim Financial Statements for the Three and Nine Months Ended September 30, 2025 99.2   Management’s Discussion and Analysis for the Three and Nine Months Ended September 30, 2025 99.3   Form 52-109F2 Certificate of Interim Filings by CEO (pursuant to Canadian regulations) 99.4   Form 52-109F2 Certificate of Interim Filings by CFO (pursuant to Canadian regulations)     EX-99.1 2 sndl-ex99_1.htm EX-99.1 EX-99.1 EXHIBIT 99.1                             SNDL Inc. Condensed Consolidated Interim Financial Statements For the three and nine months ended September 30, 2025 (Unaudited – expressed in thousands of Canadian dollars)         SNDL Inc. Condensed Consolidated Interim Statements of Financial Position (Unaudited - expressed in thousands of Canadian dollars)   As at Note September 30, 2025   December 31, 2024               Assets           Current assets           Cash and cash equivalents     240,581     218,359   Restricted cash     19,798     19,815   Marketable securities     139     139   Accounts receivable     26,299     28,118   Biological assets 5   3,507     1,187   Inventory 6   125,334 &#160